Asst Professor Valerie Yang is a Consultant, Division of Medical Oncology at the National Cancer Centre Singapore. She is jointly appointed as a Research Clinician & Group Leader at the Institute of Molecular and Cell Biology, A*STAR. Her interests include Sarcomas, Lymphomas and Melanomas.

She received the National Science Scholarship from the Agency for Science, Technology and Re-search (A*STAR) to read Medicine and a PhD. She graduated from the Royal Free and University College Medical School with Distinctions in Preclinical Medicine and First Class Honours for a Bach-elor of Science (BSc) in Molecular Medicine. She was conferred the Cluff Memorial Prize and the Goldberg-Schachmann and Freda Becker Memorial Award, and joined the A*STAR Chairman’s Honours List. Dr. Yang then read Clinical Medicine at the University of Cambridge, where she was accepted into the prestigious MB/PhD Programme. Her PhD in Oncology was supervised by Dr. Mi-chael Gonzalez and Professor Ronald Laskey, where she studied DNA replication, cell cycle regula-tion and embryonic stem cell pluripotency.

Upon returning to Singapore, Dr. Yang underwent Internal Medicine residency training and was ac-cepted to the Membership of the Royal College of Physicians (MRCP), UK, before receiving special-ty training in Medical Oncology at the NCCS. She was also conferred the Nurturing Clinician Scien-tists Scheme Award (NCSS) by SingHealth for Sarcoma research while concurrently undergoing spe-cialty training. She is now accredited as a Specialist in Medical Oncology and a Fellow of the Acad-emy of Medicine of Singapore. As an Associate Consultant, she also won the National Medical Re-search Council (NMRC) Transition Award 2021 for her work in Sarcomas.

• Fellow, College of Clinician Scientists, Academy of Medicine, Singapore, 2021
• Fellow of the Academy of Medicine, Singapore (Medical Oncology), 2019
• Specialist Accreditation in Medical Oncology, Ministry of Health Singapore, 2019
• MRCP, Royal College of Physicians (UK), 2014
• PhD, University of Cambridge, 2010
• MBBChir, University of Cambridge, 2010
• Bachelor of Science with First Class Honours, University College London, 2003

• Mentor, SingHealth Internal Medicine Residency Program, 2021 – Present
• Internal Medicine Panel, Department of Internal Medicine, Singapore General Hospital, 2021 - Present 
  
• Consultant, Division of Medical Oncology, National Cancer Centre Singapore, 2021 - Present
• Assistant Professor, Oncology Academic Clinical Program, Duke-NUS Medical School, 2021 - Present
• Clinical Physician Faculty Member, SingHealth Medical Oncology Residency Programme, 2021 – Present
• Associate Consultant, Division of Medical Oncology, National Cancer Centre Singapore, 2019 – 2021
• Research Clinician & Group Leader, Institute of Molecular and Cell Biology, A*STAR, 2019 - Present
• Adjunct Instructor, Oncology Academic Clinical Program, Duke-NUS Medical School, 2019 – 2021
• American Association for Cancer Research, 2015 - Present
• Singapore Society of Oncology (SSO), 2014 – Present
• American Society of Clinical Oncology (ASCO), 2014 – Present
• European Society of Medical Oncology (ESMO), 2014 – Present

• Singhealth Long Service Award, 2022
• National Medical Research Council (NMRC) Transition Award, 2021
• Nurturing Clinician Scientists Scheme Award, SingHealth, 2016
• Academic Development Programme, National University Hospital, 2012
• First Prize for Oral Presentation, Graduate Research Symposium, Cambridge University, 2009
• Goldberg-Schachmann and Freda Becker Memorial award, University of London, 2003
• Cluff Memorial Prize, Royal Free and University College Medical School, 2003
• Distinction in Medical Sciences, Royal Free and University College Medical School, 2003
• Chairman’s Honours List, A*STAR Graduate Academy, 2003

• National Science Scholarship (MBBS-PhD), A*STAR, 2001

• Drug screening
• Biomarkers
• Patient-derived models
• Immunotherapy
• Translational Artificial Intelligence and Machine Learning
• Single-cell and digital spatial profiling technologies
• Personalised medicine
• Cancer epigenetics
• Sarcoma, Lymphoma, Melanoma, Skin and rare cancers